))
"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai
Manage episode 406602022 series 3494116
コンテンツは Kirbie Johnson and Sara Tan, Kirbie Johnson, and Sara Tan によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Kirbie Johnson and Sara Tan, Kirbie Johnson, and Sara Tan またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Heard of "doping" when it comes to SPF? Today you'll learn all about it. Sunscreen is the most important step in your morning skincare routine, but there's still so much confusion around it, as well as challenges brands have to overcome in the US that prohibits us from having more sophisticated UV filters. Sophie Bai, biomedical engineer, cancer drug developer and the founder/CEO of Pavise is our guest today, discussing those challenges in sunscreen development and regulation, the classification of sunscreen as a drug, mislabeling of sunscreens, inaccurate SPF claims, flaws in broad spectrum testing, and what separates Pavise Dynamic Age Defense SPF 30 from other sunscreens.
Shop this episode
GlossAngelesPod.com
CALL US: 424-341-0426
Shop products from our episodes
Join our FB Group: https://www.facebook.com/groups/glossangelespodcast
Instagram: @glossangelspod, @kirbiejohnson, @saratan
Twitter: @glossangelespod, @kirbiejohnson, @saratan
Email: glossangelespodcast@gmail.com
Hosted on Acast. See acast.com/privacy for more information.
401 つのエピソード
シェア
